ArticleMolecular pharmaceutics2026
Eutectic Itraconazole and Posaconazole System and the Advantages of Its Use in the Amorphous Form.
Article in Molecular pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Itraconazole (ITR) and posaconazole (POS) exhibit closely related molecular structures but differ significantly in their ability to form liquid crystalline (LC) phases. This makes them an attractive model system to investigate how subtle structural differences influence molecular organization in the amorphous state. In this work, we investigate coamorphous systems composed of ITR and POS prepared via melt-quenching, focusing on the interplay between molecular dynamics, physical stability, and LC ordering. Differential scanning calorimetry (DSC) and broadband dielectric spectroscopy (BDS) reveal that the glass transition temperature remains nearly unchanged over a wide compositional range, indicating comparable molecular mobility of all investigated systems. Despite this similarity, a pronounced, nonmonotonic dependence of crystallization kinetics on composition is observed, with a clear stability maximum at the eutectic ratio. Strikingly, this specific composition is also associated with the complete disappearance of the LC ordering characteristic of neat ITR. While ITR-rich mixtures close to the eutectic point still exhibit residual LC transitions, the eutectic composition yields a fully disordered amorphous phase. These results demonstrate, for the first time, that coamorphization at the eutectic composition might suppress LC ordering. The findings highlight the critical role of composition in governing both molecular organization and stability in amorphous pharmaceuticals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.